Cancer Science,
Journal Year:
2022,
Volume and Issue:
113(7), P. 2297 - 2310
Published: April 29, 2022
Abstract
The
tumor
microenvironment
(TME)
is
related
to
chronic
inflammation
and
currently
identified
as
a
risk
factor
for
the
occurrence
development
of
endometrial
cancer
(EC).
Pyroptosis
new
proinflammatory
form
programmed
cell
death
that
plays
critical
role
in
progression
multiple
diseases.
However,
important
pyroptosis
high‐glucose
(HG)‐related
EC
underlying
molecular
mechanisms
remain
elusive.
In
present
study,
transcriptome
high‐throughput
sequencing
revealed
significantly
higher
hexokinase
domain‐containing
1
(HKDC1)
expression
patients
with
diabetes
than
normal
glucose.
Mechanistically,
HKDC1
regulates
HG‐induced
by
modulating
production
reactive
oxygen
species
pyroptosis‐induced
cytokine
release
EC.
addition,
TME
formation
enhancing
glycolysis,
promoting
metabolic
advantage
lactate‐rich
environments
further
accelerate
progression.
Subsequently,
miR‐876‐5p
was
predicted
target
mRNA,
HOXC‐AS2
potentially
inhibit
miR‐876‐5p/HKDC1
axis
regulating
HG‐related
Collectively,
we
elucidated
regulatory
HOXC‐AS2/miR‐876‐5p/HKDC1
signal
transduction
at
level,
which
may
provide
an
effective
therapeutic
who
are
diagnosed
Signal Transduction and Targeted Therapy,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: July 5, 2021
Abstract
Pancreatic
cancer
is
an
increasingly
common
cause
of
mortality
with
a
tight
correspondence
between
disease
and
incidence.
Furthermore,
it
usually
diagnosed
at
advanced
stage
very
dismal
prognosis.
Due
to
the
high
heterogeneity,
metabolic
reprogramming,
dense
stromal
environment
associated
pancreatic
cancer,
patients
benefit
little
from
current
conventional
therapy.
Recent
insight
into
biology
genetics
has
supported
its
molecular
classification,
thus
expanding
clinical
therapeutic
options.
In
this
review,
we
summarize
how
biological
features
reprogramming
as
well
tumor
microenvironment
regulate
development
progression.
We
further
discuss
potential
biomarkers
for
diagnosis,
prediction,
surveillance
based
on
novel
liquid
biopsies.
also
outline
recent
advances
in
defining
subtypes
subtype-specific
responses
preclinical
models.
Finally,
prospects
challenges
therapeutics.
Chemical Reviews,
Journal Year:
2024,
Volume and Issue:
124(20), P. 11242 - 11347
Published: Oct. 9, 2024
Biopsy,
including
tissue
and
liquid
biopsy,
offers
comprehensive
real-time
physiological
pathological
information
for
disease
detection,
diagnosis,
monitoring.
Fluorescent
probes
are
frequently
selected
to
obtain
adequate
on
processes
in
a
rapid
minimally
invasive
manner
based
their
advantages
biopsy.
However,
conventional
fluorescent
have
been
found
show
aggregation-caused
quenching
(ACQ)
properties,
impeding
greater
progresses
this
area.
Since
the
discovery
of
aggregation-induced
emission
luminogen
(AIEgen)
promoted
advancements
molecular
bionanomaterials
owing
unique
high
quantum
yield
(QY)
signal-to-noise
ratio
(SNR),
The Analyst,
Journal Year:
2021,
Volume and Issue:
146(12), P. 4000 - 4009
Published: Jan. 1, 2021
An
electrochemical
biosensor
employing
a
gold
nanoparticles/graphene
quantum
dots/graphene
oxide
composite
modified
electrode
is
developed
for
the
multiplex
detection
of
miRNA
breast
cancer
biomarkers.
Frontiers in Oncology,
Journal Year:
2020,
Volume and Issue:
10
Published: Oct. 21, 2020
TXNIP,
also
known
as
thioredoxin
interacting
protein,
is
a
kind
of
(TRX)
binding
which
can
mediate
oxidative
stress,
inhibit
cell
proliferation
and
induce
apoptosis
by
inhibiting
the
function
system.
In
recent
years,
TXNIP
has
attracted
attention
because
its
wide
range
functions
in
cardiovascular
diseases,
neurodegenerative
cancer,
diabetes
other
diseases.
Accumulating
evidence
demonstrated
that
abnormally
expressed
variety
malignant
tumors,
tumor
suppressor
malignancies
such
hepatoma,
breast
pancreatic
ductal
adenocarcinoma
lung
cancer.
We
know
cancer
cells
affecting
metabolic
reprogramming,
affect
invasion
metastasis
through
TXNIP-HIF1α-TWIST
signal
axis,
negatively
regulate
bladder
carcinogenesis
via
activation
ERK
induced
stromal
cell-derived
factor-1/C-X-C
chemokine
receptor
type
4
signal,
cells.
this
review,
we
summarized
be
regulated
to
transcription
factors
or
proteins,
down-regulated
epigenetic
changes
miRNA,
summarise
emerging
insights
on
expression
functional
role
different
kinds
cancers,
clarify
it
participate
reprogramming
stress
gene
proliferation,
promote
cells,
important
basic
clinical
significance
for
finding
new
molecular
targets
treatment
methods
diagnosis
tumors.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(3)
Published: Oct. 25, 2021
Pancreatic
cancer
(PC)
is
one
of
the
most
devastating
malignant
tumors.
However,
fluorescence
probes
for
early
clinical
diagnosis
PC
often
encounter
difficulties
in
accuracy
and
penetrability.
In
this
work,
an
enzyme-activated
aggregation-induced-emission
(AIE)
probe,
QM-HSP-CPP,
high-contrast
developed
by
monitoring
specific
overexpressed
enzyme
Cathepsin
E
(CTSE).
The
probe
composed
AIE
fluorophore
QM-COOH
(QM
=
quinoline-malononitrile),
CTSE-triggered
hydrophobic
peptide
(HSP),
hydrophilic
biocompatible
cell
penetrating
(CPP).
CPP
unit
can
well-modulate
molecular
dispersion
properties,
giving
initial
fluorescence-off
state
aqueous
biosystem,
thus
endowing
high
signal-to-noise
ratio,
finally
overcoming
poor
targeting
selectivity
traditional
probes.
ensure
cell/tissue
ability,
allowing
on-site
endogenous
CTSE
cells,
tissues,
living
animal
models.
When
QM-HSP-CPP
specifically
cleaved
CTSE,
it
generate
signals
situ
with
high-specificity
long-term
tracking
successfully
achieve
intraoperative
human
sections,
heterotopic
nude
mice
CTSE-enzyme-triggered
AIEgens'
liberation
strategy
improves
addresses
penetration
problem
simultaneously,
which
expand
database
multitudinous
AIE-active
probes,
especially
establishing
pathological
fluorescent
diagnosis.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(17), P. 13340 - 13340
Published: Aug. 28, 2023
There
is
an
urgent
unmet
need
for
robust
and
reliable
biomarkers
early
diagnosis,
prognosis,
prediction
of
response
to
specific
treatments
many
aggressive
deadly
cancers,
such
as
pancreatic
cancer,
liquid
biopsy-based
miRNA
profiling
has
the
potential
this.
MiRNAs
are
a
subset
non-coding
RNAs
that
regulate
expression
multitude
genes
post-transcriptionally
thus
diagnostic,
prognostic,
predictive
have
also
emerged
therapeutics.
Because
miRNAs
involved
in
post-transcriptional
regulation
their
target
mRNAs
via
repressing
gene
expression,
defects
biogenesis
pathway
perturb
oncogenic
or
tumor-suppressive
pathogenesis
various
cancers.
As
such,
numerous
been
identified
be
downregulated
upregulated
functioning
either
oncomes
oncosuppressor
miRs.
Moreover,
dysregulation
pathways
can
change
function
cancer.
Profiling
dysregulated
cancer
shown
correlate
with
disease
indicate
optimal
treatment
options
predict
therapy.
Specific
signatures
track
stages
hold
markers,
well
therapeutics
mimics
inhibitors
(antagomirs).
Furthermore,
they
along
downstream
used
therapeutic
targets.
However,
limited
understanding
validation
roles
miRNAs,
lack
tissue
specificity,
methodological,
technical,
analytical
reproducibility,
harmonization
isolation
quantification
methods,
use
standard
operating
procedures,
availability
automated
standardized
assays
improve
reproducibility
between
independent
studies
limit
bench-to-bedside
translation
clinical
applications.
Here
I
review
recent
findings
on
markers.